Intravenous Solution Market Synopsis
The global intravenous (IV) solution market is estimated to record a CAGR of 7.69% while procuring the market value of USD 11,511.2 million by 2022. The growing incidence of chronic diseases such as cholera is estimated to be one of the most significant factors driving the global intravenous (IV) solution market 2020. As per various researches conducted, cancer is estimated to expand by 70% in forthcoming decades.
Free Sample Copy of Intravenous Solution Market With Considering Coivd19 Impact on this Market @https://www.marketresearchfuture.com/sample_request/1235
Pursuant to the World Cancer Research Fund International, stomach cancer is one of the top 5 prevailing cancer forms among individuals. Such patients are ‘nil by mouth’ and are dependent on total parenteral nutrition (TPN). The increasing usage of TPN by cancer patients is estimated to fuel the IV solutions market in the forthcoming period. Further, factors such as unhealthy lifestyle, stress, inadequate diet, improper sleep have resulted in immunodeficiency disorders, which is likely to lead to a substantial rise in the demand, and thereby expanding the global market. The other significant factors leading to the expansion of the market are the increasing geriatric population, improving economic condition, increasing investment in the healthcare sector are some of the other significant factors growing the market substantially. Moreover, the IV solutions have evolved with technologies leading to the improvement in overall functions. Besides, the increasing popularity of IV led treatments and therapies aiming towards curing cancer is another vital factor in expanding the worldwide market.
Intravenous Solution Market Segmentation
The segment analysis of the global IV solutions market is done by types, nutritional contents, and end-users.
The type-based segments of the global IV solutions market are total parenteral solution, and peripheral parenteral solution, among others.
The nutritional contents -based segments of the global IV solutions market are carbohydrates, amino acid solution, vitamins & minerals, and parenteral lipid emulsion, among others.
The end-users based segments of the global IV solutions market are ambulatory, hospitals & clinics, and home care, among others.
Intravenous Solution Market Regional Analysis
Based on the region, the global IV solution market is primarily segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). As per the research conducted by MRFR, the global market is projected to be dominated by North America, followed by Europe and Asia-Pacific, respectively.
North America is estimated to dominate the global market by procuring the largest market revenue owing to developed healthcare infrastructure. Further, the US has a hefty allocation for healthcare, which assists in developing the healthcare industry. In addition, the rising prevalence of immunodeficiency disorder and the increasing demand for treatment measures are likely to stimulate the market significantly.
Europe is projected to acquire the second position in the IV solution market. The region is prospering on account of high per capita income and the robust penetration in the healthcare sector. Countries like Germany, France make a vital contribution to expanding the market significantly. Further, the region is estimated to witness a significant rise in chronic diseases, recording a phenomenal CAGR during the evaluation period.
The APAC market is estimated to exhibit an exponential growth owing to the surging population demanding medical treatment. The key markets of APAC are India and China, which play a crucial role in developing the regional market. Further, with the advent of superior quality and enhanced healthcare infrastructure, the APAC IV market is estimated to record a CAGR of 8.34% during the assessment period from 2016 to 2022.
Intravenous Solution Market Key Players
The renowned players of the market are ICU Medical, Inc. (US), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), Baxter (US), Amanta Healthcare (India), Terumo Medical Corporation (Tokyo), and Grifols S.A. (Spain) among others.
OBTAIN RESEARCH REPORT DETAILS WITH TOC @https://www.marketresearchfuture.com/reports/intravenous-solution-market-1235
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar